Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017

Details for Mechanism ID: 13562
Country/Region: Zambia
Year: 2016
Main Partner: Chreso Ministries
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: HHS/CDC
Total Funding: $0 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $0
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Age/sex: <1 2017 143
HTS_TST Age/sex: 1-9 2017 605
HTS_TST Age/sex: 10-14 Female 2017 390
HTS_TST Age/sex: 10-14 Male 2017 365
HTS_TST Age/sex: 15-19 Female 2017 811
HTS_TST Age/sex: 15-19 Male 2017 671
HTS_TST Age/sex: 20-24 Female 2017 1,541
HTS_TST Age/sex: 20-24 Male 2017 1,244
HTS_TST Age/sex: 25-49 Female 2017 2,113
HTS_TST Age/sex: 25-49 Male 2017 2,241
HTS_TST Age/sex: 50+ Female 2017 491
HTS_TST Age/sex: 50+ Male 2017 421
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 799
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 716
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 4,830
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 4,691
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 11,036
HTS_TST Service Delivery Point (Facility): Index testing 2017 207
HTS_TST Service Delivery Point (Facility): Inpatient 2017 37
HTS_TST Service Delivery Point (Facility): Outpatient 2017 27
HTS_TST Service Delivery Point (Facility): Pediatric 2017 23
HTS_TST Service Delivery Point (Facility): PMTCT 2017 170
HTS_TST Service Delivery Point (Facility): VCT 2017 10,572
HTS_TST Sum of Age/Sex disaggregates 2017 10,288
HTS_TST Sum of Aggregated Age/Sex <15 2017 1,515
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 9,521
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 11,036
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 18
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 14
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 43
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 27
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 155
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 88
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 346
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 356
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 51
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 48
HTS_TST_POS Test Result by Age: Positive: <1 2017 5
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 52
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 90
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 72
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 556
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 537
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 2,700
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 2,700
KP_PREV Total estimated number of key population in the catchment area 2017 2,700
KP_PREV_den By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) 2017 2,700
PMTCT_ART Already on ART at beginning of current pregnancy 2017 79
PMTCT_ART New on ART 2017 94
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 4,516
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 75
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 44
PMTCT_EID Sum of Infant Age disaggregates 2017 119
PMTCT_STAT By Age (DREAMS SNUs ONLY): <15 2017 68
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 145
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 523
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 597
PMTCT_STAT By Age (DREAMS SNUs ONLY): 50+ 2017 62
PMTCT_STAT By: Known positives at entry 2017 474
PMTCT_STAT By: Number of new positives identified 2017 273
PMTCT_STAT Number of new ANC and L&D clients 2017 4,997
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 4,516
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: <15 2017 13
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 15-19 2017 33
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 20-24 2017 108
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 25-49 2017 140
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 50+ 2017 13
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: <15 2017 14
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 15-19 2017 28
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 20-24 2017 92
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 25-49 2017 131
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 50+ 2017 14
PMTCT_STAT Sum of Positives Status disaggregates 2017 747
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15 2017 21
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15-19 2017 215
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 20-24 2017 1,893
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 25-49 2017 2,068
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 50+ 2017 72
PP_PREV Aggregated Age/sex: <15 Female 2017 5,687
PP_PREV Aggregated Age/sex: <15 Male 2017 5,607
PP_PREV Aggregated Age/sex: 15+ Female 2017 32,207
PP_PREV Aggregated Age/sex: 15+ Male 2017 31,724
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 75,225
PP_PREV Total number of people in the target population 2017 57,030
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 4
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 199
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 3
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 144
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 129
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 350
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 12,053
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 8,294
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 946
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 661
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 21,954
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 33
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 884
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 33
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 788
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 1,738
TX_CURR Age/Sex: <1 2017 110
TX_CURR Age/Sex: <1-9 2017 564
TX_CURR Age/Sex: 10-14 Female 2017 568
TX_CURR Age/Sex: 10-14 Male 2017 432
TX_CURR Age/Sex: 15-19 Female 2017 1,215
TX_CURR Age/Sex: 15-19 Male 2017 965
TX_CURR Age/Sex: 20-24 Female 2017 4,695
TX_CURR Age/Sex: 20-24 Male 2017 2,468
TX_CURR Age/Sex: 25-49 Female 2017 2,976
TX_CURR Age/Sex: 25-49 Male 2017 1,973
TX_CURR Age/Sex: 50+ Female 2017 617
TX_CURR Age/Sex: 50+ Male 2017 508
TX_CURR Aggregated Age/Sex: <15 Female 2017 788
TX_CURR Aggregated Age/Sex: <15 Male 2017 602
TX_CURR Aggregated Age/Sex: 15+ Female 2017 9,162
TX_CURR Aggregated Age/Sex: 15+ Male 2017 6,539
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 17,091
TX_CURR Sum of age/sex disaggregates 2017 2,180
TX_CURR Sum of Aggregated Age/Sex <15 2017 1,390
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 15,701
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 17,091
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 114
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 96
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 1,188
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 906
TX_NEW By Age/Sex: <1 2017 6
TX_NEW By Age/Sex: 1-9 2017 80
TX_NEW By Age/Sex: 10-14 Female 2017 56
TX_NEW By Age/Sex: 10-14 Male 2017 47
TX_NEW By Age/Sex: 15-19 Female 2017 99
TX_NEW By Age/Sex: 15-19 Male 2017 93
TX_NEW By Age/Sex: 20-24 Female 2017 153
TX_NEW By Age/Sex: 20-24 Male 2017 98
TX_NEW By Age/Sex: 25-49 Female 2017 893
TX_NEW By Age/Sex: 25-49 Male 2017 686
TX_NEW By Age/Sex: 50+ Female 2017 54
TX_NEW By Age/Sex: 50+ Male 2017 39
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 2,304
TX_NEW Sum of Age/Sex disaggregates 2017 2,218
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 2,304
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 580
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 569
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 37
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 21
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 289
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 222
TX_PVLS Numerator: Indication: Routine 2017 55
TX_PVLS Numerator: Indication: Targeted 2017 514
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 36
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 21
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 297
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 226
TX_PVLS_den Denominator: Indication: Routine 2017 55
TX_PVLS_den Denominator: Indication: Targeted 2017 525
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 4
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 15
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 15
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 10
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 6
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 10
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 317
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 191
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 253
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 152
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 63
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 46
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 40
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 23
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 634
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 385
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 1,082
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 1,083
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 4
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 15
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 15
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 10
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 7
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 10
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 318
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 191
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 252
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 152
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 64
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 45
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 40
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 22
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 635
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 386